GL1X · GenesisL1 explorer

Research workbench

VAV1 inhibited by an allosteric inhibitor: VAV1 inhibitors block gef activity

Analyse VAV1 inhibited by an allosteric inhibitor: VAV1 inhibitors block gef activity in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
6NFA
Type
protein
Length
386 residues
Chains
1
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Proto-oncogene vav
UniProt
P15498
Ligands
9K1, ZN
Pockets
4 · best druggability 0.61

Structure

x-ray diffraction · 1 distinct chain · 55% helix, 17% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
AProto-oncogene vavprotein38655% helix, 17% strandP15498

Ligands and binding sites

  • 9K1 · (2S)-2-{[3-(4-methylphenyl)imidazo[1,2-a]pyrazin-8-yl]amino}-3-(pyridin-3-yl)propan-1-ol · ligand · chains A
  • ZN · Zinc ion · metal · 2 copies · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

4 pockets found on a 1 Å grid, 1 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
11770.610.83299K1
21410.430.7624empty
3550.310.7615empty
4590.300.7411empty

Compared structures

  • 6NFA · Vav1 inhibited by an allosteric inhibitor: Vav1 inhibitors block GEF activity · the same entry in another collection · chain A against A, TM-score 1.00
  • P15498 · AlphaFold monomer V2.0 prediction for proto-oncogene vav (P15498) · a predicted model of the same protein · chain A against A, TM-score 0.94

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.